CareDx Stock (NASDAQ: CDNA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 979.288K |
Day Range | - - - |
52 Wk Range | 4.800 - 12.930 |
Market Cap | $544.710M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 9.17% |
Days to Cover | 4.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CareDx (NASDAQ: CDNA) through any online brokerage.
Other companies in CareDx’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Altimmune (NASDAQ:ALT) and Replimune Group (NASDAQ:REPL).
The latest price target for CareDx (NASDAQ: CDNA) was reported by Stephens & Co. on Thursday, November 9, 2023. The analyst firm set a price target for 10.00 expecting CDNA to fall to within 12 months (a possible -4.94% downside). 6 analyst firms have reported ratings in the last year.
The stock price for CareDx (NASDAQ: CDNA) is $10.52 last updated March 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for CareDx.
CareDx’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for CareDx.
CareDx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.